Choroidal nevus is the most frequently occurring primary intraocular tumor.
1 This condition poses two associated risks: first, a benign nevus can transform into malignant melanoma, with risks of melanoma-related metastasis and mortality; and second, nevi may lead to vision impairment from subretinal fluid or secondary choroidal neovascularization.
2,3 Early detection and careful progression monitoring of choroidal nevi are crucial as they are early-stage precursors to choroidal melanomas.
4 Shields et al.
5 have proposed several risk factors associated with the transformation of choroidal nevus into melanoma. These risk factors include lesion thickness >2 mm, the presence of subretinal fluid, visual symptoms, the presence of orange pigment, ultrasound acoustic hollowness, and tumor basal diameter >5 mm. Clinicians rely on various imaging modalities, including color fundus photography (CFP),
6 scanning laser ophthalmoscopy (SLO),
7 fundus autofluorescence (AF),
8 optical coherence tomography (OCT),
9,10 and ultrasonography,
11 to assess these risk factors. Each of these imaging modalities has its own strengths and limitations. Consequently, multimodal imaging is often used for the assessment of choroidal nevi.
5 CFP and SLO provide two-dimensional lateral profiles of the lesion. In contrast, OCT and ultrasound images reveal depth information of nevi. Additionally, AF image can reveal the accumulation of lipofuscin, seen clinically as overlying orange pigment, suggestive of tumor activity. Ultrasonography is currently the gold standard for the measurement of intraocular tumors and provides an accurate measurement of tumor thickness using A-scan. However, it is acknowledged that B-scan ultrasonography measurements of lateral diameter are less precise for choroidal tumors, especially for choroidal nevi that appear flat due to their thinness.
7 Nevertheless, small choroidal tumors that might escape detection via ultrasonography can be objectively measured using OCT which provides high-resolution cross sectional imaging of choroidal lesions.
10,12 However, the time and cost associated with multimodal imaging may restrict its availability, particularly for patients in rural and underserved areas that lack advanced imaging technology and trained personnel.